Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection

OBJECTIVE: To compare the efficacy of adjuvant chemotherapy with six or eight cycles of S-1 plus oxaliplatin (SOX) or Capecitabine plus oxaliplatin (XELOX) after D2 resection of GC. DESIGN AND PARTICIPANTS: We collected 470 cases of patients with TNM stage II and III GC who underwent D2 gastrectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yuanyuan, Zhang, Zicheng, Meng, Qianhao, Ma, Yue, Fan, Xiaona, Sun, Jie, Wang, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181140/
https://www.ncbi.nlm.nih.gov/pubmed/34109131
http://dx.doi.org/10.3389/fonc.2021.684627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181140/
https://www.ncbi.nlm.nih.gov/pubmed/34109131
http://dx.doi.org/10.3389/fonc.2021.684627

Ejemplares similares